Attachment Bonding and Neonatal Hospitalization: the Impact of Hospitalization in a Kangaroo Unit

NCT ID: NCT06243861

Last Updated: 2024-05-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

96 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-04-10

Study Completion Date

2025-04-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The Kangaroo Unit (UK) takes care of newborns requiring special care or monitoring for a pathology whose clinical situation is stable and whose prognosis is favorable. In order to avoid separating mother and child, these units were created with a care pathway somewhere between that requiring hospitalization in a neonatal unit and that of pathology-free newborns in post-natal care. Theoretically, the mother-child bond created in the UK is as good as that created in conventional post-natal care. However, studies show that there are limits to the quality of the bond in the UK. This study aims to assess whether the mother-child bond is degraded in the UK, in comparison with that of mothers in post-natal care.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postnatal Care

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

kangaroo unit

Mother-child bond

Intervention Type BEHAVIORAL

assessing whether the mother-child bond is degraded in the UK, in comparison with that of mothers in post-natal care

postnatal care

Mother-child bond

Intervention Type BEHAVIORAL

assessing whether the mother-child bond is degraded in the UK, in comparison with that of mothers in post-natal care

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mother-child bond

assessing whether the mother-child bond is degraded in the UK, in comparison with that of mothers in post-natal care

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient over 18 years of age, hospitalized in a Kangaroo Unit or in a post-natal unit,
* Affiliated to a social security scheme,
* fluent in French
* no objection of participation

Exclusion Criteria

* Patient who :

* given birth to a child who was stillborn or died at birth
* difficulty understanding written French
* psychological incapacity (psychiatric disorder, too great a vulnerability) or physical incapacity (physical/motor disability) to answer questionnaires,
* Patient under court protection, guardianship or curatorship.
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Régional Metz-Thionville

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marie-Laure BOYE

Role: PRINCIPAL_INVESTIGATOR

CHR Metz Thionville

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHR Metz-Thionville/Hopital Mercy

Metz, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Arpiné EL NAR, PhD

Role: CONTACT

0033387557766

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Arpiné EL NAR

Role: primary

0033387557766

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023-08Obs-CHRMT

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.